The ǀxam language has been carved into a new building at Rhodes House to honour the labour and suffering of Africans during colonialism.
Articles on University of Oxford
Displaying 1 - 20 of 37 articles
The footprints were uncovered at a large quarry in Oxfordshire.
Since the 1980s very few antibiotics have been approved. One of the reasons is that there is not enough investment in the sector.
In this podcast, ANU Vice Chancellor and astrophysicist Brian Schmidt joins The Conversation to discuss the challenges universities are facing
An intriguing new history of Oxford philosophers tells the story of a cloistered world giving out under pressure from an intransigent reality.
It’s been 200 years since the discovery of one of the oldest human burial sites in western Europe on the Gower peninsula in south Wales.
Two years ago, the Recovery trial transformed COVID treatments around the world with a landmark finding that may have saved a million lives in just nine months
Research suggests our names for birds reflect our changing relationship with the natural world: here’s why that matters
In our first weekly update on COVID vaccines, we consider how roll-out plans are being tweaked and when it’s likely we’ll start to see vaccines having an impact.
What normally takes decades has been achieved in 12 months, without cutting corners.
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
Experts from across The Conversation look at how COVID-19 vaccines will work, how they’re being tested and manufactured, and what challenges there will be to rolling them out.
With Donald Trump already doing a great job of making the public more wary of a coronavirus vaccine, big pharma has to do better than this.
Stoppages of clinical trials are a normal part of the testing process, and show that patient safety is being taken seriously.
The phase 3 trials of the University of Oxford/AstraZeneca vaccine have been paused because one participant became unwell. But we don’t know for sure if the illness was a reaction to the vaccine.
The Australian government is working with two major pharmaceutical companies to facilitate the local production and supply of two different COVID-19 vaccines – if they’re proven to be effective.
The federal government has secured two possible vaccine sources with a $1.7 billion supply and production agreement with two pharmaceutical companies.
The vaccine hasn’t completed phase 3 trials, so we can’t be sure it will be safe and effective for all. The Australian government’s deal is contingent on these trials being successful.
Instead of a global response to the pandemic, we’re seeing an outbreak of vaccine nationalism.
The experimental vaccine stimulates the creation of antibodies. Now we need to show that these effectively protect us from the coronavirus.
Top contributors
-
Professor of Intellectual Property Law, Queen Mary University of London
-
Professorial Fellow, University of Canberra
-
Associate Professor, University of the Witwatersrand
-
Professor of Business Ethics, Warwick Business School, University of Warwick
-
Programme Leader and Senior Lecturer in English, Loughborough University
-
Lecturer, University of Stirling
-
Lecturer in Philosophy, University of St Andrews
-
Research fellow, University of Oxford
-
Lecturer, Maynooth University
-
Wellcome Trust Fellow, University of Cambridge
-
Junior Research Fellow, History of the modern Middle East and North Africa, University of Oxford
-
Associate Professor of English, UMass Amherst
-
Doctoral Researcher, Heriot-Watt University
-
Senior Lecturer (Education) Oxford Brookes University; College Lecturer in Social Anthropology, St. Hugh's College, University of Oxford
-
Associate Professor, Pedagogy and the Social Sciences, University of Oxford